Table 4.

Multivariate analysis of the gastric cancer collective

		(a) Whole cohort				(b) Female sex only
		HR	95.0% CI for HR		p value	HR	95.0% CI for HR		p value
			Lower	Upper			Lower	Upper
CD66b	Low	0.927	0.679	1.266	0.635	0.833	0.453	1.530	0.556
	High				Ref				Ref
UICC	Overall				0.000				0.000
	UICC 1	0.104	0.061	0.176	0.000	0.050	0.016	0.154	0.000
	UICC 2	0.137	0.085	0.220	0.000	0.124	0.051	0.298	0.000
	UICC 3	0.395	0.261	0.599	0.000	0.384	0.176	0.839	0.016
	UICC 4				Ref				Ref
Age	< 50 years	0.622	0.383	1.010	0.055	0.530	0.260	1.083	0.082
	> 50 years				Ref				Ref
Sex	Male	1.108	0.801	1.533	0.535
	Female				Ref
Treatment	Primary surgery	0.817	0.593	1.125	0.215	0.804	0.442	1.462	0.474
	Neoadjuvant treatment				Ref				Ref
TCGA	Overall				0.653				0.824
	CIN				Ref				Ref
	GS	0.968	0.620	1.512	0.886	1.316	0.628	2.758	0.467
	MSI	0.700	0.404	1.212	0.203	0.734	0.218	2.478	0.619
	EBV	0.942	0.482	1.842	0.862	0.929	0.199	4.341	0.926

CI Confidence interval, HR Hazard ratio, TCGA The Cancer Genome Atlas, UICC Union internationale contre le cancer, CIN chromosomal instability, MSI microsatellite instability, GS genomically stable, EBV Epstein–Barr virus-positive